![Marcus Irsfeld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcus Irsfeld
Direttore Finanziario/CFO presso
VIVORYON THERAPEUTICS N.V.
Patrimonio netto: - $ in data 30/09/2026
Profilo
Mr. Marcus Irsfeld is a Chief Financial Officer & Executive Director at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Artract Medical, Inc. Mr. Irsfeld was previously employed as a Chief Financial Officer by ProCorde GmbH and a Controller by Trigen Holdings AG.
He received his undergraduate degree from the University of Münster.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/09/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Posizioni attive di Marcus Irsfeld
| Società | Posizione | Inizio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Direttore Finanziario/CFO | 01/12/2025 |
Artract Medical, Inc.
 Artract Medical, Inc. Medical SpecialtiesHealth Technology Manufactures hemodynamic assist device | Fondatore | - |
Precedenti posizioni note di Marcus Irsfeld
| Società | Posizione | Fine |
|---|---|---|
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Comptroller/Controller/Auditor | 15/12/2009 |
ProCorde GmbH
 ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Develops biomedical drugs for cardiovascular diseases | Direttore Finanziario/CFO | 11/04/2005 |
Formazione di Marcus Irsfeld
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
ProCorde GmbH
ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Develops biomedical drugs for cardiovascular diseases | Commercial Services |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Develops drugs focusing on thrombosis and vascular dysfunction | Commercial Services |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Artract Medical, Inc.
Artract Medical, Inc. Medical SpecialtiesHealth Technology Manufactures hemodynamic assist device | Health Technology |
